No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Amivantamab-lazertinib is Effective for Epidermal Growth Factor Receptor Mutated Non-Small Cell Lung Cancer

byAngel GaoandAlisha Yi

July 22, 2024

in StudyGraphics

Reading Time: 1 min read

Click here to read this study in NEJM.

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Structured exercise intervention improves survival in colon cancer patients

2 Minute Medicine: Pharma Roundup – Gastric Immunotherapy Gains, Prostate Pill Expansion, Five-Minute Myeloma Dosing, and Streamlined CAR-T Access [July 8th 2025]

Tumor-infiltrating clonal hematopoiesis is associated with NSCLC recurrence

Multi-Organ Immune-related Adverse Events from Immune Checkpoint Inhibitors

RelatedReports

Development of a risk index for colorectal cancer screening

Gastroenterology

Structured exercise intervention improves survival in colon cancer patients

July 9, 2025

Pharma

2 Minute Medicine: Pharma Roundup – Gastric Immunotherapy Gains, Prostate Pill Expansion, Five-Minute Myeloma Dosing, and Streamlined CAR-T Access [July 8th 2025]

July 8, 2025

Lessons from real-world implementation of lung cancer screening

Oncology

Tumor-infiltrating clonal hematopoiesis is associated with NSCLC recurrence

July 7, 2025

All Specialties

Minimally invasive surgery is beneficial for epithelial ovarian cancer

July 4, 2025

The Scan by 2 Minute Medicine®: Kate Middleton's Hair: Chemo Mysteries, MRI Screening: Is It Useful?, Biden's COVID Amid Variant Surge, Avoiding Microplastics

Association between Childhood Housing Insecurity and Adolescent Health Outcomes

Rapid growth of medical artificial intelligence technology usage identified from insurance claims analysis, yet major barriers to widespread adoption remain

A large language model demonstrates superior cost-effectiveness in screening heart failure candidates for clinical trials

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports